Cancer Treatment market research reports by GlobalData

• Canada Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Canada Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• BRIC Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibro

  Apr 28, 2023  |  Published by: GlobalData  |  USD 3,995

  BRIC Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

• France Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  France Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

• Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Sum ... Read More

• Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031

  Apr 28, 2023  |  Published by: GlobalData  |  USD 9,995

  Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for m ... Read More

• Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031

  Apr 28, 2023  |  Published by: GlobalData  |  USD 9,995

  Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for markete ... Read More

• Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

• Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast t ... Read More

• North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uter

  Apr 28, 2023  |  Published by: GlobalData  |  USD 3,995

  North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 ... Read More

• Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  Apr 26, 2023  |  Published by: GlobalData  |  USD 2,500

  Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2023 provides an overview of D ... Read More

• Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  Mar 27, 2023  |  Published by: GlobalData  |  USD 2,500

  Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) C ... Read More

• Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  Feb 27, 2023  |  Published by: GlobalData  |  USD 2,500

  Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spons ... Read More

• Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  Feb 24, 2023  |  Published by: GlobalData  |  USD 9,995

  Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecas ... Read More

• Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  Feb 14, 2023  |  Published by: GlobalData  |  USD 9,995

  Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-b ... Read More

• Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  Jan 31, 2023  |  Published by: GlobalData  |  USD 2,500

  Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, ... Read More

• B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Jan 31, 2023  |  Published by: GlobalData  |  USD 3,495

  B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in B-cell NHL therapeutics. Synopsis There are more than 1.7 million diagnosed prev ... Read More

• Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033

  Jan 27, 2023  |  Published by: GlobalData  |  USD 7,500

  Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033 Summary Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Ana ... Read More

• Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  Jan 24, 2023  |  Published by: GlobalData  |  USD 9,995

  Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patien ... Read More

• Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  Jan 24, 2023  |  Published by: GlobalData  |  USD 9,995

  Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year pati ... Read More

• Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  Jan 20, 2023  |  Published by: GlobalData  |  USD 9,995

  Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast ... Read More

• HER2 Amplification Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033

  Jan 19, 2023  |  Published by: GlobalData  |  USD 7,500

  HER2 Amplification Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 Summary HER2 Amplification Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impa ... Read More

• Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Jan 04, 2023  |  Published by: GlobalData  |  USD 3,495

  Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in bladder cancer therapeutics. Synopsis In 2022, there will be more than 460,000 diagnosed incident c ... Read More

< prev 1 2 3 4 5 next >